Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1634.5 39.35 (2.47%) Market Cap: 150.72 Bil Enterprise Value: 170.45 Bil PE Ratio: 64.92 PB Ratio: 6.62 GF Score: 68/100

Q1 2023 Strides Pharma Science Ltd Earnings Call Transcript

Jul 29, 2022 / 10:30AM GMT
Release Date Price: ā‚¹331.35 (-0.85%)
Operator

Ladies and gentlemen, good day, and welcome to Strides Pharma Science Limited Q1 FY '23 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Abhishek Singhal. Thank you, and over to you, sir.

Abhishek Singhal

Yes, very good afternoon, and thank you for joining us today for Strides earnings call for the first quarter ended financial year 2023. Today, we have with us our Arun, Founder, Executive Chairman and Managing Director; Badree, Executive Director, Finance and Group CFO, to share the highlights of the business and financials for the quarter. I hope you have gone through our results release and the quarterly investor presentation, which have been uploaded on our website as well as stock exchange. The transcript of this call will be available in a week's time on the company's website.

Please note that today's discussion may be forward-looking in nature and must be reviewed in relation to the risks pertaining to our business.

After the end of this call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot